Trial · NCT01285713
IV Glucose for Dehydration Treatment
NCT01285713, Phase 2, Completed, Children's Hospital of Philadelphia; results first posted 2013-01-23
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. IV Glucose for Dehydration Treatment. Trials, record NCT01285713. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01285713
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- IV Glucose for Dehydration Treatment
- NCT number
- NCT01285713
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 83 participants, actual
- Lead sponsor
- Children's Hospital of Philadelphia
- Conditions
- Dehydration
- Interventions
- 5% Dextrose (D5) in Normal Saline (NS), Normal Saline (NS)
- First posted
- 2011-01-28
- Last updated
- 2019-03-19
- Results first posted
- 2013-01-23
- Limitations and caveats
- Single center study Small sample size Enrollment available 16 hours/day Evaluated one dextrose load of 500mg/kg
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Measurement of Serum Ketones Before and After Administration of Intravenous Fluids for Acute Gastroenteritis | 4 hours | Measurement of serum ketones by bedside ketone meter before and after administration of IVF for both groups to determine a change in serum ketones. The hypothesis is that dextrose containing IVF will lead to a decrease in serum ketones in children with acute gastroenteritis who require IV rehydration. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Measurement of Serum Ketones Before and After Administration of Intravenous Fluids for Acute Gastroenteritis | 4 hours | mmol/L | MEAN |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Measurement of Serum Ketones Before and After Administration of Intravenous Fluids for Acute Gastroenteritis | D5Normal Saline | 1.10 | Standard Deviation 1.20 | mmol/L | |
| Measurement of Serum Ketones Before and After Administration of Intravenous Fluids for Acute Gastroenteritis | Normal Saline | 2.39 | Standard Deviation 1.62 | mmol/L |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | 5% Dextrose (D5) in Normal Saline (NS) | 42 | |
| Overall Study | STARTED | Normal Saline (NS) | 41 | |
| Overall Study | COMPLETED | 5% Dextrose (D5) in Normal Saline (NS) | 42 | |
| Overall Study | COMPLETED | Normal Saline (NS) | 41 | |
| Overall Study | NOT COMPLETED | 5% Dextrose (D5) in Normal Saline (NS) | 0 | |
| Overall Study | NOT COMPLETED | Normal Saline (NS) | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | D5Normal Saline | ||
| Total, all-cause mortality | Normal Saline | ||
| Total, other adverse events | D5Normal Saline | 0 | 41 |
| Total, other adverse events | Normal Saline | 0 | 42 |
| Total, serious adverse events | D5Normal Saline | 0 | 41 |
| Total, serious adverse events | Normal Saline | 0 | 42 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| D5Normal Saline vs Normal Saline: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01285713
GET https://conductscience.org/api/trials/v1/NCT01285713/registered